Kiyono H, Michalek S M, Mosteller L M, Torii M, Hamada S, McGhee J R
Scand J Immunol. 1982 Dec;16(6):455-63. doi: 10.1111/j.1365-3083.1982.tb00746.x.
The induction of immune responses to orally administered trinitrophenyl (TNP)-haptenated Streptococcus mutans and its enhancement with muramyldipeptide (MDP), peptidoglycan (PG), and concanavalin A (Con A) were investigated in lipopolysaccharide (LPS)-non-responsive C3H/HeJ mice and the syngeneic, LPS-responsive C3H/HeN strain. Both mouse strains manifested similar immune responses, primarily of the IgM isotype, after a single gastric intubation (GI) with TNP-S. mutans. However, when groups of animals were first carrier-primed by GI with S. mutans for 2 consecutive days, followed by a single GI with TNP-S. mutans 1 week later, C3H/HeJ mice gave a significantly higher (P less than or equal to 0.01) splenic IgA anti-TNP plaque-forming cell (PFC) response than identically treated C3H/HeN mice. Furthermore, saliva, urine and serum from these C3H/HeJ mice possessed high levels of IgA anti-TNP antibodies as determined by the enzyme-linked immunosorbent assay, whereas C3H/HeN mice exhibited low antibody levels. Oral administration of Con A (either 250 micrograms or 500 micrograms/mouse) or purified PG (1 mg/mouse) at the time of TNP-S. mutans immunization resulted in significantly (P less than or equal to 0.01) enhanced splenic IgA anti-TNP PFC responses, especially in C3H/HeJ mice. On the other hand, MDP promoted IgA anti-TNP PFC responses in LPS-responsive C3H/HeN mice but did not augment responses in C3H/HeJ animals. A similar immune response pattern was seen when antibody levels were measured in serum, saliva, and urine of both mouse strains. These results demonstrate that haptenated S. mutans is a good antigen for the induction of high IgA responses in orally immunized C3H/HeJ mice and that this high response can be enhanced with the adjuvants Con A and PG. However, MDP is ineffective in C3H/HeJ mice but enhances IgA responses in normal LPS-responsive C3H/HeN animals.
研究了在无脂多糖(LPS)反应性的C3H/HeJ小鼠和同基因的、有LPS反应性的C3H/HeN品系中,口服三硝基苯基(TNP)偶联变形链球菌后免疫反应的诱导情况,以及用胞壁酰二肽(MDP)、肽聚糖(PG)和刀豆球蛋白A(Con A)对其进行增强的效果。在用TNP-变形链球菌进行单次胃内插管(GI)后,两种小鼠品系均表现出相似的免疫反应,主要为IgM同种型。然而,当动物组先连续2天经GI用变形链球菌进行载体预致敏,1周后再经GI给予一次TNP-变形链球菌时,C3H/HeJ小鼠脾脏中IgA抗TNP空斑形成细胞(PFC)反应显著高于(P≤0.01)接受相同处理的C3H/HeN小鼠。此外,通过酶联免疫吸附测定法测定,这些C3H/HeJ小鼠的唾液、尿液和血清中含有高水平的IgA抗TNP抗体,而C3H/HeN小鼠的抗体水平较低。在给予TNP-变形链球菌进行免疫时,口服Con A(250微克或500微克/只小鼠)或纯化的PG(1毫克/只小鼠)可显著(P≤0.01)增强脾脏中IgA抗TNP PFC反应,尤其是在C3H/HeJ小鼠中。另一方面,MDP可促进有LPS反应性 的C3H/HeN小鼠的IgA抗TNP PFC反应,但对C3H/HeJ动物的反应无增强作用。在测定两种小鼠品系的血清、唾液和尿液中的抗体水平时,也观察到了类似的免疫反应模式。这些结果表明,偶联TNP的变形链球菌是在口服免疫的C3H/HeJ小鼠中诱导高IgA反应的良好抗原,并且这种高反应可用佐剂Con A和PG增强。然而,MDP在C3H/HeJ小鼠中无效,但可增强正常有LPS反应性的C3H/HeN动物的IgA反应。